Samantha L. Hocking

Samantha L. Hocking

Auto-generated profile, based on publicly available information

Samantha L. Hocking

Boden Initiative, Charles Perkins Centre University of Sydney Sydney New South Wales Australia

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Endocrine Reviews
Verified
Journal Article
Closed access
SHSamantha Hocking
Samantha Hocking
Dorit Samocha-BonetDorit Samocha-Bonet
Dorit Samocha-Bonet
KMKerry-Lee Milner
Kerry-Lee Milner
JGJerry R. Greenfield
Jerry R. Greenfield
DCDonald J. Chisholm
Donald J. Chisholm
Human adiposity has long been associated with insulin resistance and increased cardiovascular risk, and abdominal adiposity is considered particularly adverse. Intra-abdominal fat is associated with insulin resistance, possibly mediated by greater lipolytic activity, lower adiponectin levels, resistance to leptin, and increased inflammatory cytokines, although the latter contribution is less clear. Liver lipid is also closely associated with, and likely to be an important contributor to, insulin resistance, but it may also be in part the consequence of the lipogenic pathway of insulin action being up-regulated by hyperinsulinemia and unimpaired signaling. Again, intramyocellular triglyceride is associated with muscle insulin resistance, but anomalies include higher intramyocellular triglyceride in insulin-sensitive athletes and women (vs men). Such issues could be explained if the “culprits” were active lipid moieties such as diacylglycerol and ceramide species, dependent more on lipid metabolism and partitioning than triglyceride amount.Subcutaneous fat, especially gluteofemoral, appears metabolically protective, illustrated by insulin resistance and dyslipidemia in patients with lipodystrophy. However, some studies suggest that deep sc abdominal fat may have adverse properties.Pericardial and perivascular fat relate to atheromatous disease, but not clearly to insulin resistance.There has been recent interest in recognizable brown adipose tissue in adult humans and its possible augmentation by a hormone, irisin, from exercising muscle. Brown adipose tissue is metabolically active, oxidizes fatty acids, and generates heat but, because of its small and variable quantities, its metabolic importance in humans under usual living conditions is still unclear.Further understanding of specific roles of different lipid depots may help new approaches to control obesity and its metabolic sequelae.

1 October 2019 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
DFDaniel Fazakerley
Daniel Fazakerley
JKJames R. Krycer
James R. Krycer
AKAlison L. Kearney
Alison L. Kearney
SHSamantha L. Hocking
Samantha L. Hocking
DJDavid E. James
David E. James
Daniel J. Fazakerley, James R. Krycer, Alison L. Kearney, Samantha L. Hocking, David E. James

26 April 2024 in Nature Reviews Nephrology
Verified
Journal Article
Closed access
PDF file
DODaniel V. O’hAra
Daniel V. O’hAra
CLCarolyn S. P. Lam
Carolyn S. P. Lam
JMJohn J. V. McMurray
John J. V. McMurray
TYTae Won Yi
Tae Won Yi
SHSamantha Hocking
Samantha Hocking
MJMeg J. Jardine
Meg J. Jardine

14 September 2010 in Diabetes
Verified
Journal Article
Open access
SHSamantha L. Hocking
Samantha L. Hocking
LWLindsay E. Wu
Lindsay E. Wu
MGMichael Guilhaus
Michael Guilhaus
DCDonald J. Chisholm
Donald J. Chisholm
DJDavid E. James
David E. James
OBJECTIVE: Visceral adipose tissue (VAT) is more closely linked to insulin resistance than subcutaneous adipose tissue (SAT). We conducted a quantitative analysis of the secretomes of VAT and SAT to identify differences in adipokine secretion that account for the adverse metabolic consequences of VAT. RESEARCH DESIGN AND METHODS: We used lectin affinity chromatography followed by comparison of isotope-labeled amino acid incorporation rates to quantitate relative differences in the secretomes of VAT and SAT explants. Because adipose tissue is composed of multiple cell types, which may contribute to depot-specific differences in secretion, we isolated preadipocytes and microvascular endothelial cells (MVECs) and compared their secretomes to those from whole adipose tissue. RESULTS: Although there were no discrete depot-specific differences in the secretomes from whole adipose tissue, preadipocytes, or MVECS, VAT exhibited an overall higher level of protein secretion than SAT. More proteins were secreted in twofold greater abundance from VAT explants compared with SAT explants (59% versus 21%), preadipocytes (68% versus 0%), and MVECs (62% versus 15%). The number of proteins in the whole adipose tissue secretome was greater than the sum of its cellular constituents. Finally, almost 50% of the adipose tissue secretome was composed of factors with a role in angiogenesis. CONCLUSIONS: VAT has a higher secretory capacity than SAT, and this difference is an intrinsic feature of its cellular components. In view of the number of angiogenic factors in the adipose tissue secretome, we propose that VAT represents a more readily expandable tissue depot.

20 March 2019 in Journal of Proteome Research
Verified
Journal Article
Open access
DHDylan J. Harney
Dylan J. Harney
AHAmy T. Hutchison
Amy T. Hutchison
LHLuke Hatchwell
Luke Hatchwell
SHSean J. Humphrey
Sean J. Humphrey
DJDavid E. James
David E. James
MLMark Larance
Mark Larance
Intermittent fasting (IF) increases lifespan and decreases metabolic disease phenotypes and cancer risk in model organisms, but the health benefits of IF in humans are less clear. Human plasma derived from clinical trials is one of the most difficult sample sets to analyze using mass spectrometry-based proteomics due to the extensive sample preparation required and the need to process many samples to achieve statistical significance. Here, we describe an optimized and accessible device (Spin96) to accommodate up to 96 StageTips, a widely used sample preparation medium enabling efficient and consistent processing of samples prior to LC-MS/MS. We have applied this device to the analysis of human plasma from a clinical trial of IF. In this longitudinal study employing 8-weeks IF, we identified significant abundance differences induced by the IF intervention, including increased apolipoprotein A4 (APOA4) and decreased apolipoprotein C2 (APOC2) and C3 (APOC3). These changes correlated with a significant decrease in plasma triglycerides after the IF intervention. Given that these proteins have a role in regulating apolipoprotein particle metabolism, we propose that IF had a positive effect on lipid metabolism through modulation of HDL particle size and function. In addition, we applied a novel human protein variant database to detect common protein variants across the participants. We show that consistent detection of clinically-relevant peptides derived from both alleles of many proteins is possible, including some that are associated with human metabolic phenotypes. Together, these findings illustrate the power of accessible workflows for proteomics analysis of clinical samples to yield significant biological insight.

22 April 2015 in Diabetologia
Verified
Journal Article
Open access
PDF file
SHSamantha L. Hocking
Samantha L. Hocking
RSRebecca L. Stewart
Rebecca L. Stewart
ABAmanda E. Brandon
Amanda E. Brandon
ESEurwin Suryana
Eurwin Suryana
ESElla Stuart
Ella Stuart
MSMichael M. Swarbrick
Michael M. Swarbrick
Adipose tissue (AT) distribution is a major determinant of mortality and morbidity in obesity. In mice, intra-abdominal transplantation of subcutaneous AT (SAT) protects against glucose intolerance and insulin resistance (IR), but the underlying mechanisms are not well understood. We investigated changes in adipokines, tissue-specific glucose uptake, gene expression and systemic inflammation in male C57BL6/J mice implanted intra-abdominally with either inguinal SAT or epididymal visceral AT (VAT) and fed a high-fat diet (HFD) for up to 17 weeks. Glucose tolerance was improved in mice receiving SAT after 6 weeks, and this was not attributable to differences in adiposity, tissue-specific glucose uptake, or plasma leptin or adiponectin concentrations. Instead, SAT transplantation prevented HFD-induced hepatic triacylglycerol accumulation and normalised the expression of hepatic gluconeogenic enzymes. Grafted fat displayed a significant increase in glucose uptake and unexpectedly, an induction of skeletal muscle-specific gene expression. Mice receiving subcutaneous fat also displayed a marked reduction in the plasma concentrations of several proinflammatory cytokines (TNF-α, IL-17, IL-12p70, monocyte chemoattractant protein-1 [MCP-1] and macrophage inflammatory protein-1β [ΜIP-1β]), compared with sham-operated mice. Plasma IL-17 and MIP-1β concentrations were reduced from as early as 4 weeks after transplantation, and differences in plasma TNF-α and IL-17 concentrations predicted glucose tolerance and insulinaemia in the entire cohort of mice (n = 40). In contrast, mice receiving visceral fat transplants were glucose intolerant, with increased hepatic triacylglycerol content and elevated plasma IL-6 concentrations. Intra-abdominal transplantation of subcutaneous fat reverses HFD-induced glucose intolerance, hepatic triacylglycerol accumulation and systemic inflammation in mice.